Nanoform Q1 2023 interim report – A strong start to the new year
Company Announcement Nanoform Finland Plc May 25, 2023 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform Q1 2023 interim report – A strong start to the new year A strong start to the new year. “Multi-API” license received, the clinical manufacture for “Project Blockbuster” commenced, 13 new non-GMP deals signed & three new major pharma relationships initiated, while the operating free cash flow has started to improve – a trend expected to continue in the coming quarters as our shift from investing & building to improving productivity & cash flow intensifies. The